ProfileGDS5678 / 1453148_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 42% 43% 42% 44% 44% 48% 41% 42% 42% 51% 44% 45% 47% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0060542
GSM967853U87-EV human glioblastoma xenograft - Control 22.9870343
GSM967854U87-EV human glioblastoma xenograft - Control 32.9800242
GSM967855U87-EV human glioblastoma xenograft - Control 42.9588944
GSM967856U87-EV human glioblastoma xenograft - Control 52.9692944
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2183248
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.0192141
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9543442
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9394642
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1959351
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0083944
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0272845
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1147
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9756742